The emerging therapeutic potential of sirtuin-interacting drugs: From cell death to lifespan extension

Trends in Pharmacological Sciences

Volumn 26, Issue 2, 2005, Pages 94-103

  Porcu, Marco ^a   Chiarugi, Alberto ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

3,6,3',4' TETRAHYDROXYFLAVONE; 5,7,3',4',5' PENTAHYDROXYFLAVONE; A 3; BUTEIN; CARBAMIDONICOTINAMIDE ADENINE DINUCLEOTIDE; COUMARIN DERIVATIVE; DIHYDROCOUMARIN; DNA DIRECTED RNA POLYMERASE; ENZYME ACTIVATOR; FISTEIN; FLAVONE DERIVATIVE; HYDROLASE INHIBITOR; ISOLIQUIRITIGENIN; LUTEOLIN; M 15; NICOTINAMIDE; PICEATANNOL; PYRAN DERIVATIVE; QUERCETIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; RESVERATROL; RIBOSOME DNA; SIRTINOL; SIRTUIN; SIRTUIN ACTIVATOR; SIRTUIN INHIBITOR; SPLITOMICIN; UNCLASSIFIED DRUG;

ACETYLATION; AGING; CANCER; CELL DEATH; CELL SURVIVAL; CHROMATIN; DIABETES MELLITUS; DRUG MECHANISM; DRUG PROTEIN BINDING; HEART FAILURE; HUMAN; MUSCLE DEVELOPMENT; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SEQUENCE HOMOLOGY; YEAST;

ANIMALS; CELL DEATH; CELL SURVIVAL; CHEMISTRY, PHARMACEUTICAL; HUMANS; ITALY; LONGEVITY; SIRTUINS;

EID: 12844271254     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tips.2004.12.009     Document Type: Review

References (79)

1. T. Jenuwein, and C.D. Allis Translating the histone code Science 293 2001 1074 1080
2. G. Egger Epigenetics in human disease and prospects for epigenetic therapy Nature 429 2004 457 463
3. T. Kouzarides Acetylation: a regulatory modification to rival phosphorylation? EMBO J. 19 2000 1176 1179
4. R.W. Johnstone Histone-deacetylase inhibitors: novel drugs for the treatment of cancer Nat. Rev. Drug Discov. 1 2002 287 299
5. C.M. Grozinger, and S.L. Schreiber Deacetylase enzymes: biological functions and the use of small-molecule inhibitors Chem. Biol. 9 2002 3 16
6. L. Guarente Sir2 links chromatin silencing, metabolism, and aging Genes Dev. 14 2000 1021 1026
7. S.M. Gasser, and M.M. Cockell The molecular biology of the SIR proteins Gene 279 2001 1 16
8. G. Blander, and L. Guarente The Sir2 family of protein deacetylases Annu. Rev. Biochem. 73 2004 417 435
9. S.W. Buck Diversity in the Sir2 family of protein deacetylases J. Leukoc. Biol. 75 2004 939 950
10. D.W. Lamming Small molecules that regulate lifespan: evidence for xenohormesis Mol. Microbiol. 53 2004 1003 1009
11. A. Bedalov Identification of a small molecule inhibitor of Sir2p Proc. Natl. Acad. Sci. U. S. A. 98 2001 15113 15118
12. K.J. Bitterman Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast sir2 and human SIRT1 J. Biol. Chem. 277 2002 45099 45107
13. R.M. Anderson Nicotinamide and PNC1 govern lifespan extension by calorie restriction in Saccharomyces cerevisiae Nature 423 2003 181 185
14. M.C. Motta Mammalian SIRT1 represses forkhead transcription factors Cell 116 2004 551 563
15. D. Robyr Microarray deacetylation maps determine genome-wide functions for yeast histone deacetylases Cell 109 2002 437 446
16. R.A. Frye Characterization of five human cDNAs with homology to the yeast SIR2 gene: Sir2-like proteins (sirtuins) metabolize NAD and may have protein ADP-ribosyltransferase activity Biochem. Biophys. Res. Commun. 260 1999 273 279
17. R.A. Frye Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins Biochem. Biophys. Res. Commun. 273 2000 793 798
18. S. Imai Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase Nature 403 2000 795 800
19. M. Fulco Sir2 regulates skeletal muscle differentiation as a potential sensor of the redox state Mol. Cell 12 2003 51 62
20. M.W. McBurney The absence of SIR2alpha protein has no effect on global gene silencing in mouse embryonic stem cells Mol. Cancer Res. 1 2003 402 409
21. M.W. McBurney The mammalian SIR2alpha protein has a role in embryogenesis and gametogenesis Mol. Cell. Biol. 23 2003 38 54
22. H.L. Cheng Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice Proc. Natl. Acad. Sci. U. S. A. 100 2003 10794 10799
23. B.J. North The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase Mol. Cell 11 2003 437 444
24. B. Schwer The human silent information regulator (Sir)2 homologue hSIRT3 is a mitochondrial nicotinamide adenine dinucleotide-dependent deacetylase J. Cell Biol. 158 2002 647 657
25. P. Onyango SIRT3, a human SIR2 homologue, is an NAD-dependent deacetylase localized to mitochondria Proc. Natl. Acad. Sci. U. S. A. 99 2002 13653 13658
26. J. Landry The silencing protein SIR2 and its homologs are NAD-dependent protein deacetylases Proc. Natl. Acad. Sci. U. S. A. 97 2000 5807 5811
27. J.S. Smith A phylogenetically conserved NAD+-dependent protein deacetylase activity in the Sir2 protein family Proc. Natl. Acad. Sci. U. S. A. 97 2000 6658 6663
28. J. Landry Role of NAD(+) in the deacetylase activity of the SIR2-like proteins Biochem. Biophys. Res. Commun. 278 2000 685 690
29. J.C. Tanny, and D. Moazed Coupling of histone deacetylation to NAD breakdown by the yeast silencing protein Sir2: Evidence for acetyl transfer from substrate to an NAD breakdown product Proc. Natl. Acad. Sci. U. S. A. 98 2001 415 420
30. A.A. Sauve Chemistry of gene silencing: the mechanism of NAD+-dependent deacetylation reactions Biochemistry 40 2001 15456 15463
31. M.D. Jackson, and J.M. Denu Structural identification of 2′- and 3′-O-acetyl-ADP-ribose as novel metabolites derived from the Sir2 family of beta -NAD+-dependent histone/protein deacetylases J. Biol. Chem. 277 2002 18535 18544
32. M.T. Borra Conserved enzymatic production and biological effect of O-acetyl-ADP-ribose by silent information regulator 2-like NAD+-dependent deacetylases J. Biol. Chem. 277 2002 12632 12641
33. J.H. Chang Structural basis for the NAD-dependent deacetylase mechanism of Sir2 J. Biol. Chem. 277 2002 34489 34498
34. K. Zhao Structural basis for nicotinamide cleavage and ADP-ribose transfer by NAD(+)-dependent Sir2 histone/protein deacetylases Proc. Natl. Acad. Sci. U. S. A. 101 2004 8563 8568
35. M.T. Borra Substrate specificity and kinetic mechanism of the Sir2 family of NAD+-dependent histone/protein deacetylases Biochemistry 43 2004 9877 9887
36. M.D. Jackson Mechanism of nicotinamide inhibition and transglycosidation by Sir2 histone/protein deacetylases J. Biol. Chem. 278 2003 50985 50998
37. J.L. Avalos Structural basis for the mechanism and regulation of Sir2 enzymes Mol. Cell 13 2004 639 648
38. R.M. Anderson Yeast life-span extension by calorie restriction is independent of NAD fluctuation Science 302 2003 2124 2126
39. M.T. Schmidt Co-enzyme specificity of Sir2 protein deacetylases: implications for physiological regulation J. Biol. Chem. 279 2004 40122 40129
40. B.K. Kennedy Mutation in the silencing gene SIR4 can delay aging in S. cerevisiae Cell 80 1995 485 496
41. M. Kaeberlein The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms Genes Dev. 13 1999 2570 2580
42. H.A. Tissenbaum, and L. Guarente Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans Nature 410 2001 227 230
43. J. Koubova, and L. Guarente How does calorie restriction work? Genes Dev. 17 2003 313 321
44. S.J. Lin Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae Science 289 2000 2126 2128
45. J.G. Wood Sirtuin activators mimic caloric restriction and delay aging in metazoans Nature 430 2004 686 689
46. S.J. Lin, and L. Guarente Nicotinamide adenine dinucleotide, a metabolic regulator of transcription, longevity and disease Curr. Opin. Cell Biol. 15 2003 241 246
47. J.M. Denu Linking chromatin function with metabolic networks: Sir2 family of NAD(+)-dependent deacetylases Trends Biochem. Sci. 28 2003 41 48
48. J.J. Sandmeier Telomeric and rDNA silencing in Saccharomyces cerevisiae are dependent on a nuclear NAD(+) salvage pathway Genetics 160 2002 877 889
49. R.M. Anderson Manipulation of a nuclear NAD+ salvage pathway delays aging without altering steady-state NAD+ levels J. Biol. Chem. 277 2002 18881 18890
50. S.J. Lin Calorie restriction extends Saccharomyces cerevisiae lifespan by increasing respiration Nature 418 2002 344 348
51. T. Araki Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration Science 305 2004 1010 1013
52. Revollo, J.R. et al. The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells. J. Biol. Chem. (in press)
53. S.J. Lin Calorie restriction extends yeast life span by lowering the level of NADH Genes Dev. 18 2004 12 16
54. A. Chiarugi PARP-1: killer or conspirator? The suicide hypothesis revisited Trends Pharmacol. Sci. 23 2002 122 129
55. J. Zhang Are poly(ADP-ribosyl)ation by PARP-1 and deacetylation by Sir2 linked? BioEssays 25 2003 808 814
56. F. Berger The new life of a centenarian: signalling functions of NAD(P) Trends Biochem. Sci. 29 2004 111 118
57. V. Muth Acetylation of TAF(I)68, a subunit of TIF-IB/SL1, activates RNA polymerase I transcription EMBO J. 20 2001 1353 1362
58. T. Senawong Involvement of the histone deacetylase SIRT1 in chicken ovalbumin upstream promoter transcription factor (COUP-TF)-interacting protein 2-mediated transcriptional repression J. Biol. Chem. 278 2003 43041 43050
59. O.R. Bereshchenko Acetylation inactivates the transcriptional repressor BCL6 Nat. Genet. 32 2002 606 613
60. J. Luo Negative control of p53 by Sir2alpha promotes cell survival under stress Cell 107 2001 137 148
61. H. Vaziri hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase Cell 107 2001 149 159
62. E. Langley Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence EMBO J. 21 2002 2383 2396
63. A. Brunet Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase Science 303 2004 2011 2015
64. H. Daitoku Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity Proc. Natl. Acad. Sci. U. S. A. 101 2004 10042 10047
65. M.E. Giannakou, and L. Partridge The interaction between FOXO and SIRT1: tipping the balance towards survival Trends Cell Biol. 14 2004 408 412
66. F. Yeung Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase EMBO J. 23 2004 2369 2380
67. F. Picard Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma Nature 429 2004 771 776
68. H.Y. Cohen Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase Science 305 2004 390 392
69. N.S. Bae Human histone deacetylase SIRT2 Interacts with the homeobox transcription factor HOXA10 J. Biochem. (Tokyo) 135 2004 695 700
70. L.A. Rafty Analysis of O-acetyl-ADP-ribose as a target for Nudix ADP-ribose hydrolases J. Biol. Chem. 277 2002 47114 47122
71. K.T. Howitz Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan Nature 425 2003 191 196
72. E. Middleton Jr The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer Pharmacol. Rev. 52 2000 673 751
73. R.R. Alcendor Silent information regulator 2α, a longevity factor and Class III histone deacetylase, is an essential endogenous apoptosis inhibitor in cardiac myocytes Circ. Res 95 2004 971 980
74. J.A. Mattison Calorie restriction in rhesus monkeys Exp. Gerontol. 38 2003 35 46
75. S.D. Tyner p53 mutant mice that display early ageing-associated phenotypes Nature 415 2002 45 53
76. H.Y. Cohen Acetylation of the C terminus of Ku70 by CBP and PCAF controls Bax-mediated apoptosis Mol. Cell 13 2004 627 638
77. C.M. Grozinger Identification of a class of small molecule inhibitors of the sirtuin family of NAD-dependent deacetylases by phenotypic screening J. Biol. Chem. 276 2001 38837 38843
78. M. Hirao Identification of selective inhibitors of NAD+-dependent deacetylases using phenotypic screens in yeast J. Biol. Chem. 278 2003 52773 52782
79. J. Posakony Inhibitors of Sir2: evaluation of splitomicin analogues J. Med. Chem. 47 2004 2635 2644